Welcome to our dedicated page for TD SYNNEX SEC filings (Ticker: SNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TD SYNNEX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TD SYNNEX's regulatory disclosures and financial reporting.
TD SYNNEX CORP (SNX) director and officer Dennis Polk reported indirect sales of company common stock held by the Polk Family Trust. On August 17, 2026, the trust sold 2,500 shares in multiple open-market transactions at weighted-average prices reflecting ranges from $258.44 to $264.59, under a Rule 10b5-1 trading plan adopted on January 16, 2026. Following these transactions, Polk reported 22,439 shares of TD SYNNEX common stock held directly.
SYNNEX (SNX) insider affiliates filed to sell 10,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $2,587,400.00, on or after August 17, 2026. The shares were acquired from the issuer as Restricted Stock Awards on October 20, 2021. Recent sales disclosed over the prior three months total several tranches between 2,500 and 15,000 shares each, including transactions identified as 10b5-1 sales by the Polk Family Trust and direct sales by Dennis Polk.
TD SYNNEX director Richard T. Hume reported selling an aggregate 5,000 shares of common stock on August 5, 2026, in seven open-market transactions at weighted-average prices between $258.295 and $264.915 per share. The sales were executed under a Rule 10b5-1 trading plan adopted on February 2, 2026.
FMR LLC reported beneficial ownership of 6,444,529.80 shares of TD SYNNEX CORP common stock (CUSIP 87162W100) on a Schedule 13G/A Amendment No. 27, reflecting holdings as of June 30, 2026. This position represents 8.0% of the outstanding common stock.
FMR LLC is listed with 6,329,993.84 shares of sole voting power and 6,444,529.80 shares of sole dispositive power, with no shared voting or dispositive power. Abigail P. Johnson is also identified as a reporting person with 6,444,529.80 shares of sole dispositive power and no voting power. One or more other persons may receive dividends or sale proceeds related to these shares, but no such person holds more than five percent of the class.
Richard T. Hume has filed a notice relating to the potential sale of 5,000 shares of common stock through Goldman Sachs & Co. LLC, to be traded on the NYSE on or after August 5, 2026, with an indicated aggregate value of $1,315,350. These shares were originally acquired on June 30, 2020 as compensation in the form of Restricted Stock Units from the issuer.
The filing also lists prior transactions over the past three months, each for 5,000 shares of common stock, with aggregate sale amounts of $1,169,228.50 on May 5, 2026, $1,401,899.50 on June 2, 2026, $1,214,862.50 on July 6, 2026, and $1,147,688.00 on May 18, 2026.
TD SYNNEX Corporation’s compensation committee approved new forms of Hyve Solutions performance-based restricted stock unit award agreements on July 28, 2026. The agreements cover both U.S. and non-U.S. participants and are intended for use under the company’s 2020 Stock Incentive Plan.
The awards are structured as performance-based restricted stock units that vest based on achieving performance targets tied to the financial performance of Hyve Solutions US Global Holding Corporation over a three-year performance period, and require continuous service with the Hyve Solutions business through the end of that period. For employees outside the U.S., a consolidated non-U.S. global template is used, with country-specific appendices for local disclosures and agreements.
TD SYNNEX CORP director Ann F Vezina reported selling 1,273 shares of common stock on July 31, 2026, in a transaction described as an open-market or private sale at $256.05 per share. After this sale, she directly owns 5,828 TD SYNNEX shares. The Rule 10b5-1 plan checkbox was not marked.
TD Synnex Corporation filed a Form 144 related to potential sales of its common stock. The filing lists an entry for common shares through Raymond James and Associates Inc., associated with figures 1273, 325,989.84, and 79,958,752, with a noted date of 07/31/2026 and NYSE as the trading market.
It also references three future stock grant entries of TD Synnex common stock with amounts of 509 (dated 11/30/2025), 508 (dated 02/28/2026), and 256 (dated 05/31/2026). These figures outline securities that may be sold under this notice.
Vanguard Portfolio Management LLC filed an amended Schedule 13G reporting its beneficial ownership in TD SYNNEX Corp common stock. Vanguard reports beneficial ownership of 3,925,662 shares, representing 4.88% of the outstanding common stock. Vanguard has sole voting power over 15,767 shares and sole dispositive power over 3,925,662 shares, with no shared voting or dispositive power reported. The filing explains that these shares include securities held by various Vanguard-affiliated entities and Vanguard funds or client accounts over which they exercise voting and/or dispositive power, and confirms that no other single person has an interest in more than 5% of the class through these holdings.
Britt Douglas reported acquisition or exercise transactions in this Form 4 filing.
TD SYNNEX director Douglas Britt received an award of 629 shares of restricted common stock under the 2020 Stock Incentive Plan, prorated for the period between his appointment and the 2027 annual meeting of shareholders. The restricted stock vests 25% on the last day of each of the four fiscal quarters following the grant, and he now holds 629 shares directly.